Estriol & Cognition in Multiple Sclerosis

Brief Description Of Study

The purpose of this study is to determine whether the combination of treatment with available MS therpies and estriol has an effect on cognitive function and disease activity and outcomes.

Clinical Study Identifier: TX259

Detailed Study Description

Eligible participants include women with all forms of Multiple Sclerosis on a stable dose of FDA approved MS therapy for 90 days or more. Patients may be off MS therapy, but also for 90 days or more and medically stable. Participants must be able to walk 330 feet without rest (unilateral assistance, such as a cane is allowed). Males are not eligible to participate.

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Estriol & Cognition in Multiple Sclerosis
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.